tiprankstipranks
Accelerate Diagnostics (AXDX)
NASDAQ:AXDX

Accelerate Diagnostics (AXDX) Financial Statements

285 Followers

Accelerate Diagnostics Financial Overview

Accelerate Diagnostics's market cap is currently ―. The company's EPS TTM is $-6.118; its P/E ratio is -0.17; Accelerate Diagnostics is scheduled to report earnings on March 28, 2024, and the estimated EPS forecast is $-0.75. See an overview of income statement, balance sheet, and cash flow financials.
Sep 23Jun 23Mar 23Dec 22Sep 22
Income Statement-
Total Revenue$ 3.30M$ 2.92M$ 2.81M$ 2.97M$ 2.96M
Gross Profit$ 107.00K$ 799.00K$ 1.01M$ 651.00K$ 579.00K
EBIT$ 1.04M$ -32.58M$ -15.37M$ -13.42M$ -15.20M
EBITDA$ 1.86M$ -32.52M$ -13.81M$ -11.98M$ -14.43M
Net Income Common Stockholders$ 7.08M$ -32.73M$ -16.80M$ -14.80M$ -15.90M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 21.15M$ 29.28M$ 29.41M$ 34.91M$ 55.39M
Total Assets$ 39.32M$ 49.88M$ 51.00M$ 65.02M$ 75.85M
Total Debt$ 36.57M$ 36.57M$ 60.60M$ 60.68M$ 76.90M
Net Debt$ 15.42M$ 7.29M$ 31.20M$ 25.78M$ 21.51M
Total Liabilities$ 74.36M$ 88.54M$ 89.73M$ 87.28M$ 85.64M
Stockholders Equity$ -35.03M$ -38.66M$ -38.73M$ -22.26M$ -9.80M
Cash Flow-
Free Cash Flow$ 7.70M$ -10.97M$ -13.38M$ -9.66M$ -13.57M
Operating Cash Flow$ 8.46M$ -10.82M$ -13.37M$ -9.56M$ -13.57M
Investing Cash Flow$ -354.00K$ 915.00K$ 8.21M$ 5.84M$ 15.79M
Financing Cash Flow$ 3.18M$ 9.81M$ -77.00K$ -126.00K$ 32.04M
Currency in USD

Accelerate Diagnostics Earnings and Revenue History

Accelerate Diagnostics Debt to Assets

Accelerate Diagnostics Cash Flow

Accelerate Diagnostics Forecast EPS vs Actual EPS

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis